Chemical Compound

[(1R,3S,4E,6E,9S,10E,12E,14R,15S,18R)-9-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-3-yl] acetate

CAS Registry Number 23477-98-7
返回搜索 申请报价
[(1R,3S,4E,6E,9S,10E,12E,14R,15S,18R)-9-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-3-yl] acetate 结构式
Primary record

[(1R,3S,4E,6E,9S,10E,12E,14R,15S,18R)-9-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-3-yl] acetate

库存
9,854 克
纯度
99.7 %
CAS
23477-98-7

化合物标识与属性

CAS
23477-98-7
PubChem CID
6917975
SMILES
C[C@@H]1[C@H]2C[C@@H](/C=C/C(=C/C[C@@H](/C=C/C(=C/[C@H]([C@@](C1=O)(C(=O)O2)C)NC(=O)C(=O)C)/C)O)/C)OC(=O)C
Canonical SMILES
CC(=O)O[C@@H]1/C=C/C(C)=C/C[C@H](O)/C=C/C(C)=C/[C@@H](NC(=O)C(C)=O)[C@]2(C)C(=O)O[C@H](C1)[C@@H](C)C2=O

名称与同义词

  • Sedecamycin
  • Lankacidin A
  • Sedecamicina
  • Sedecamycine
  • Sedecamycinum
  • Bundlin B
  • Takelan
  • Sedecamicina [Spanish]
  • BUNDLIN
  • Sedecamycine [French]
  • Sedecamycinum [Latin]
  • AC1OCEVC
  • Antibiotic T-2636 B
  • SEDECAMYCIN [MI]
  • RefChem:931568
  • Antibiotic T-2636 A
  • Lankacidin C 14-acetate
  • SEDECAMYCIN [INN]
  • SEDECAMYCIN [JAN]
  • Sedecamycin (USAN/INN)
  • Sedecamycin [USAN:INN]
  • SEDECAMYCIN [USAN]
  • WLK252Z51F
  • T-2636A
  • UNII-WLK252Z51F
  • SCHEMBL2109024
  • CHEMBL2105460
  • NSC-145117
  • C27H35NO8
  • DTXCID90909735
  • DTXSID501318285
  • Ro 23-0731/000
  • Antibiotic T-2636 C 14-acetate
  • Ro-230731000
  • 23477-98-7
  • BBF-00189
  • C27-H35-N-O8
  • ZINC56897707
  • CID6917975
  • NSC 145117
  • T-2636
  • RO-23-0731/000
  • HY-127093
  • D05811
  • 102648-23-7
  • Q27292706
  • [(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-2-(2-oxopropanoylamino)-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-13-yl] acetate
  • ((1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-2-(2-oxopropanoylamino)-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-13-yl) acetate
  • ((3E,5E,9E,11E)-7-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-2-(2-oxopropanoylamino)-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-13-yl) acetate
  • (-)-N-((1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)pyruvamide 13-acetate
  • [(1R,3S,4E,6E,9S,10E,12E,14R,15S,18R)-9-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-3-yl] acetate
  • [(4E,6E,10E,12E)-9-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-3-yl] acetate